Case Study: a leading biopharmaceutical company achieves 90% forecasting accuracy with L.E.K. Consulting's predictive epidemiology model

a biopharma giant achieves 90% forecast accuracy with LEK Consulting

The customer, a leading biopharmaceutical company, faced unprecedented challenges in forecasting demand for its COVID-19 products across seven major markets due to rapidly evolving virus variants. Traditional models were ineffective, so the company engaged L.E.K. Consulting to develop a robust and flexible predictive epidemiology model.

L.E.K. Consulting developed and implemented a sophisticated short-term predictive model, including a variant library and a custom user interface. The solution was deployed on the client's AWS environment. L.E.K. Consulting's model delivered over 90% forecast accuracy, informed critical manufacturing and supply decisions, and provided long-term strategic planning tools for a 10-year horizon, enabling the client to swiftly adapt to the evolving pandemic.